Healthinvest Partners Ab is an investment fund managing more than $164 billion ran by Margareta Spjut. There are currently 38 companies in Mrs. Spjut’s portfolio. The largest investments include Eli Lilly Co and UFP Technologies, together worth $40.7 billion.
As of 7th August 2024, Healthinvest Partners Ab’s top holding is 27,144 shares of Eli Lilly Co currently worth over $24.6 billion and making up 15.0% of the portfolio value.
In addition, the fund holds 31,680 shares of UFP Technologies worth $16.1 billion, whose value grew 67.4% in the past six months.
The third-largest holding is Merck Co Inc worth $14 billion and the next is Thermo Fisher Scientific worth $10.8 billion, with 19,458 shares owned.
Currently, Healthinvest Partners Ab's portfolio is worth at least $164 billion. The total portfolio value may be much higher due to cash
assets that are not publicly disclosed such as fixed income, real estate, or cash equivalents.
The Healthinvest Partners Ab office and employees reside in Stockholm, Sweden. According to the last 13-F report filed with the SEC, Margareta Spjut serves as the Operations Manager at Healthinvest Partners Ab.
In the most recent 13F filing, Healthinvest Partners Ab revealed that it had opened a new position in
UFP Technologies and bought 9,800 shares worth $2.59 billion.
This means they effectively own approximately 0.1% of the company.
UFP Technologies makes up
13.8%
of the fund's Materials sector allocation and has grown its share price by 83.2% in the past year.
The investment fund also strengthened its position in Eli Lilly Co by buying
6,366 additional shares.
This makes their stake in Eli Lilly Co total 27,144 shares worth $24.6 billion.
On the other hand, there are companies that Healthinvest Partners Ab is getting rid of from its portfolio.
Healthinvest Partners Ab closed its position in Elevance Health Inc on 14th August 2024.
It sold the previously owned 7,400 shares for $3.84 billion.
Margareta Spjut also disclosed a decreased stake in Merck Co Inc by 0.2%.
This leaves the value of the investment at $14 billion and 112,734 shares.
The two most similar investment funds to Healthinvest Partners Ab are Windle Wealth and Sciencast Management L.P.. They manage $164 billion and $164 billion respectively.
Healthinvest Partners Ab’s portfolio is diversified across 4 sectors.
Currently, their heaviest sector is Health Care — making up 56.3% of
the total portfolio value.
The fund focuses on investments in the United States as
68.4% of the portfolio companies
are based in the United States.
The majority of the companies in the fund’s portfolio are large-cap stocks.
Stocks with a size of more than $10 billion in market cap make up
34% of the total holdings value.
On the other hand, small-cap stocks make up only approximately 0.1% of the portfolio.
The average market cap of the portfolio companies is close to $40 billion.
These positions were updated on August 14th based on the fund’s latest 13F filing. Quickly find out what the most recently closed or increased positions are.
| Security | Shares Owned | Value | Allocation |
|---|---|---|---|
| Eli Lilly Co |
30.64%
27,144
|
$24,575,634,000 | 14.98% |
| UFP Technologies Inc. |
37.49%
31,680
|
$16,133,356,000 | 9.84% |
| Merck Co Inc |
15.71%
112,734
|
$13,956,469,000 | 8.51% |
| Thermo Fisher Scientific Inc. |
28.13%
19,458
|
$10,760,274,000 | 6.56% |
| AMGEN Inc. |
46.04%
27,589
|
$8,620,183,000 | 5.26% |
| Boston Scientific Corp. |
37.67%
106,557
|
$8,205,954,000 | 5.00% |
| Regeneron Pharmaceuticals, Inc. |
27.81%
6,893
|
$7,244,749,000 | 4.42% |
| Vertex Pharmaceuticals, Inc. |
33.64%
15,095
|
$7,075,328,000 | 4.31% |
| Cencora Inc. |
48.44%
30,320
|
$6,831,096,000 | 4.17% |
| Stryker Corp. |
31.87%
19,983
|
$6,799,215,000 | 4.15% |
| Abbvie Inc |
21.37%
35,618
|
$6,109,199,000 | 3.73% |
| Dexcom Inc |
31.20%
34,483
|
$3,909,682,000 | 2.38% |
| Elevance Health Inc |
Closed
7,400
|
$3,837,196,000 | |
| Gilead Sciences, Inc. |
Closed
52,000
|
$3,809,000,000 | |
| Edwards Lifesciences Corp |
47.35%
36,505
|
$3,371,966,000 | 2.06% |
| Neurocrine Biosciences, Inc. |
45.65%
23,630
|
$3,253,142,000 | 1.98% |
| Fusion Pharmaceuticals Inc. |
Closed
138,836
|
$2,959,984,000 | |
| IQVIA Holdings Inc |
39.03%
13,984
|
$2,956,776,000 | 1.80% |
| Molina Healthcare Inc |
20.83%
9,500
|
$2,824,350,000 | 1.72% |
| Cardinal Health, Inc. |
No change
27,500
|
$2,703,800,000 | 1.65% |
| UFP Technologies Inc. |
Opened
9,800
|
$2,585,926,000 | 1.58% |
| Mirum Pharmaceuticals Inc |
38.86%
75,200
|
$2,571,088,000 | 1.57% |
| Intra-Cellular Therapies Inc |
5.81%
35,841
|
$2,454,750,000 | 1.50% |
| Ionis Pharmaceuticals Inc |
36.21%
40,691
|
$1,939,333,000 | 1.18% |
| Merus N.V |
26.77%
30,837
|
$1,824,625,000 | 1.11% |
| Corbus Pharmaceuticals Hldgs |
2.89%
39,100
|
$1,769,275,000 | 1.08% |
| Alkermes plc |
Opened
68,800
|
$1,658,080,000 | 1.01% |
| Shockwave Med Inc |
Closed
4,751
|
$1,547,068,000 | |
| Option Care Health, Inc. |
59.07%
54,395
|
$1,506,741,000 | 0.92% |
| Amicus Therapeutics Inc |
41.26%
148,207
|
$1,470,213,000 | 0.90% |
| Newamsterdam Pharma Company |
238.46%
75,794
|
$1,456,002,000 | 0.89% |
| Krystal Biotech Inc |
15.10%
7,624
|
$1,400,071,000 | 0.85% |
| BridgeBio Pharma Inc |
41.20%
53,432
|
$1,353,432,000 | 0.83% |
| Arcellx Inc |
28.58%
22,496
|
$1,241,554,000 | 0.76% |
| Exact Sciences Corp. |
Closed
16,120
|
$1,113,247,000 | |
| Harmony Biosciences Hldgs In |
79.47%
34,900
|
$1,052,933,000 | 0.64% |
| Inspire Med Sys Inc |
Closed
4,782
|
$1,027,126,000 | |
| Cytokinetics Inc |
Closed
14,000
|
$981,540,000 | |
| Madrigal Pharmaceuticals Inc |
Closed
3,539
|
$945,055,000 | |
| Immunocore Hldgs Plc |
41.86%
23,778
|
$805,836,000 | 0.49% |
| Autolus Therapeutics plc |
134.72%
226,145
|
$786,984,000 | 0.48% |
| Morphic Hldg Inc |
35.09%
20,199
|
$688,179,000 | 0.42% |
| Pharvaris N V |
Opened
34,328
|
$645,366,000 | 0.39% |
| Akero Therapeutics Inc |
Closed
24,432
|
$617,152,000 | |
| Macrogenics Inc |
190.85%
143,407
|
$609,479,000 | 0.37% |
| Cabaletta Bio Inc |
17.05%
64,321
|
$481,121,000 | 0.29% |
| Mersana Therapeutics Inc |
84.90%
184,900
|
$371,649,000 | 0.23% |
| No transactions found | |||
| Showing first 500 out of 47 holdings | |||